We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Hutchison China MediTech

ASCO 2020: savo and suru data drives regulatory progress

Update | 04 June 2020

Mereo BioPharma

Private placement raises $70m (£56m)

Lighthouse | 04 June 2020

Nexstim

€2.3m rights issue is 273% subscribed

Update | 02 June 2020

Futura Medical

Nearing the critical point in Erectile Dysfunction

Outlook | 02 June 2020

MaxCyte

ASCO poster shows encouraging data for MCY-M11

Lighthouse | 02 June 2020

Bonesupport

SEK 378m raised through directed share issue

Lighthouse | 28 May 2020

MaxCyte

Enabling cell therapies to progress

Outlook | 26 May 2020

Nexstim

Hitting the right spot

Update | 22 May 2020

Scancell

COVID 2nd generation vaccine opportunity is all upside

Update | 11 May 2020

Scancell

Reasons to be cheerful

Outlook | 11 May 2020
1 2 3 4 5 6 7 8 9 10 >
241 results found.